Show
Sort by
-
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors
-
Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model
-
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
-
Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management
-
18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial
-
- Journal Article
- A1
- open access
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
-
- Journal Article
- A1
- open access
Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer
-
- Journal Article
- A1
- open access
Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice